Julia Carnevale, MD

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
Address513 Parnassus Avenue, HSW
San Francisco CA 94143
ORCID ORCID Icon0000-0001-9410-7148 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Stanford University, StanfordB.A.05/2005Human Biology
    Harvard Medical School, BostonM.D.05/2011Cancer Biology
    UCSF, San Francisco06/2013Internal Medicine Residency
    UCSF, San Francisco06/2017Oncology - ABIM Research Pathway

    Collapse Overview 
    Collapse Overview
    Dr. Carnevale is a physician-scientist who treats patients with gastrointestinal cancers, and also performs research into finding novel therapies for these diseases.

    Collapse Research 
    Collapse Research Activities and Funding
    Using CRISPR engineering to develop more potent T cell therapies that are resistant to suppression in the tumor microenvironment
    Burroughs Wellcome Fund 1020881Sep 1, 2020 - Aug 31, 2025
    Role: Principle Investigator
    Description: The goal of this project is to 1) evaluate genes that regulate intrinsic fitness of T cell therapies 2) investigate genetic determinants of T cell responses to suppressive factors found in the tumor microenvironment, and 3) develop preclinical models that better predict optimal T cell therapeutic strategies for solid tumors.
    Targeting SOCS1 and RASA2 to Engineer More Potent Adoptive T Cell Therapies for Cancer Treatment.
    NIH K08CA252605Jul 15, 2020 - Jun 30, 2025
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. RASA2 ablation in T cells boosts antigen sensitivity and long-term function. Nature. 2022 09; 609(7925):174-182. Carnevale J, Shifrut E, Kale N, Nyberg WA, Blaeschke F, Chen YY, Li Z, Bapat SP, Diolaiti ME, O'Leary P, Vedova S, Belk J, Daniel B, Roth TL, Bachl S, Anido AA, Prinzing B, Ibañez-Vega J, Lange S, Haydar D, Luetke-Eversloh M, Born-Bony M, Hegde B, Kogan S, Feuchtinger T, Okada H, Satpathy AT, Shannon K, Gottschalk S, Eyquem J, Krenciute G, Ashworth A, Marson A. PMID: 36002574; PMCID: PMC9433322.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    2. Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence. Cancer Cell. 2022 07 11; 40(7):768-786.e7. Belk JA, Yao W, Ly N, Freitas KA, Chen YT, Shi Q, Valencia AM, Shifrut E, Kale N, Yost KE, Duffy CV, Daniel B, Hwee MA, Miao Z, Ashworth A, Mackall CL, Marson A, Carnevale J, Vardhana SA, Satpathy AT. PMID: 35750052.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    3. Phase II study of pembrolizumab plus capecitabine and bevacizumab in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 2022 Jun 1; 40(16_suppl):3565-3565. Bocobo BA, Wang WR, Behr BS, Carnevale CJ, Cinar CP, Collisson CE, Fong FL, Keenan KB, Kidder KW, Ko KA, Kolli KK, Kennedy KM, Laffan LA, Piawah PS, Pollak PM, Schwartz SG, Whitman WJ, Zhang ZL, Van Loon VK, Atreya AC. .
      View in: Publisher Site   Mentions:
    4. The Additional Diagnostic Benefit of Pancreatic Cancer Molecular Profiling After Germline Testing. Pancreas. 2022 04 01; 51(4):302-304. Walker EJ, Blanco AM, Carnevale J, Cinar P, Collisson EA, Tempero MA, Ko AH. PMID: 35695740.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    5. Hypoxia Is a Dominant Remodeler of the Effector T Cell Surface Proteome Relative to Activation and Regulatory T Cell Suppression. Mol Cell Proteomics. 2022 04; 21(4):100217. Byrnes JR, Weeks AM, Shifrut E, Carnevale J, Kirkemo L, Ashworth A, Marson A, Wells JA. PMID: 35217172; PMCID: PMC9006863.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    6. Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic Adenocarcinoma. Oncologist. 2021 11; 26(11):e1982-e1991. Walker EJ, Goldberg D, Gordon KM, Pedley C, Carnevale J, Cinar P, Collisson EA, Tempero MA, Ko AH, Blanco AM, Dhawan M. PMID: 34506673; PMCID: PMC8571767.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    7. 512O Interim results from a phase II study of the ATR inhibitor ceralasertib in ARID1A-deficient and ARID1A-intact advanced solid tumor malignancies. Annals of Oncology. 2021 Sep 1; 32:s583. Aggarwal AR, Umetsu US, Dhawan DM, Grabowsky GJ, Carnevale CJ, Howell HM, Wilch WL, Chapman CJ, Alvarez AE, Calabrese CS, Smith SS, Shah SN, Dean DE, Munster MP, Collisson CE. .
      View in: Publisher Site   Mentions:
    8. Durable response after immune checkpoint inhibitor-related diabetes in mismatch repair-deficient pancreatic cancer. Immunotherapy. 2021 10; 13(15):1249-1254. Tsang ES, Walker EJ, Carnevale J, Fisher GA, Ko AH. PMID: 34338034.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    9. Investigating tumor molecular profiling as a possible contributor to racial/ethnic disparities in pancreatic cancer. Journal of Clinical Oncology. 2021 May 20; 39(15_suppl):6522-6522. Walker WE, Piawah PS, Griffin GA, Carnevale CJ, Cinar CP, Collisson CE, Tempero TM, Ko KA. .
      View in: Publisher Site   Mentions:
    10. The marginal diagnostic benefit of pancreatic cancer molecular profiling after germline testing. Journal of Clinical Oncology. 2021 May 20; 39(15_suppl):10513-10513. Walker WE, Blanco BA, Carnevale CJ, Cinar CP, Collisson CE, Tempero TM, Ko KA. .
      View in: Publisher Site   Mentions:
    11. Phase II study of pembrolizumab plus capecitabine and bevacizumab in microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Interim analysis. Journal of Clinical Oncology. 2021 Jan 20; 39(3_suppl):77-77. Bocobo BA, Wang WR, Behr BS, Carnevale CJ, Cinar CP, Collisson CE, Fong FL, Kidder KW, Ko KA, Kolli KK, Kennedy KM, Laffan LA, Lindsay LS, Nalla NS, Schwartz SG, Whitman WJ, Zendejas ZP, Zhang ZL, Van Loon VK, Atreya AC. .
      View in: Publisher Site   Mentions:
    12. Combined Immunotherapy and Hypofractionated Radiotherapy for Metastatic Cancers. International Journal of Radiation Oncology • Biology • Physics. 2020 Nov 1; 108(3):e648. Sinha SS, Greene GC, Kelley KR, Cinar CP, Venook VA, Atreya AC, Gordan GJ, Carnevale CJ, Anwar AM, Feng FM. .
      View in: Publisher Site   Mentions:
    13. Abstract PR08: Discovery of immune regulators in primary human T cells using genome-wide CRISPR screens. Cancer Immunology Research. 2020 Apr 1; 8(4_Supplement):pr08-pr08. Carnevale CJ, Shifrut SE, Tobin TV, Roth RT, Woo WJ, Bui BC, Li LJ, Diolaiti DM, Ashworth AA, Marson MA. .
      View in: Publisher Site   Mentions:
    14. 3:54 PM Abstract No. 243 Phase I Prospective Trial of TAS-102 (trifluride and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases. Journal of Vascular and Interventional Radiology. 2020 Mar 1; 31(3):s109. Fidelman FN, Atreya AC, Griffith GM, Milloy MA, Carnevale CJ, Cinar CP, Venook VA, Van Loon VK. .
      View in: Publisher Site   Mentions:
    15. Phase I prospective trial of TAS-102 (trifluride and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases. Journal of Clinical Oncology. 2020 Feb 1; 38(4_suppl):110-110. Fidelman FN, Atreya AC, Griffith GM, Milloy MM, Carnevale CJ, Cinar CP, Venook VA, Van Loon VK. .
      View in: Publisher Site   Mentions:
    16. Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma. Fam Cancer. 2019 04; 18(2):241-251. Walker EJ, Carnevale J, Pedley C, Blanco A, Chan S, Collisson EA, Tempero MA, Ko AH. PMID: 30267352.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    17. Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function. Cell. 2018 12 13; 175(7):1958-1971.e15. Shifrut E, Carnevale J, Tobin V, Roth TL, Woo JM, Bui CT, Li PJ, Diolaiti ME, Ashworth A, Marson A. PMID: 30449619; PMCID: PMC6689405.
      View in: PubMed   Mentions: 150     Fields:    Translation:HumansCells
    18. Reprogramming human T cell function and specificity with non-viral genome targeting. Nature. 2018 07; 559(7714):405-409. Roth TL, Puig-Saus C, Yu R, Shifrut E, Carnevale J, Li PJ, Hiatt J, Saco J, Krystofinski P, Li H, Tobin V, Nguyen DN, Lee MR, Putnam AL, Ferris AL, Chen JW, Schickel JN, Pellerin L, Carmody D, Alkorta-Aranburu G, Del Gaudio D, Matsumoto H, Morell M, Mao Y, Cho M, Quadros RM, Gurumurthy CB, Smith B, Haugwitz M, Hughes SH, Weissman JS, Schumann K, Esensten JH, May AP, Ashworth A, Kupfer GM, Greeley SAW, Bacchetta R, Meffre E, Roncarolo MG, Romberg N, Herold KC, Ribas A, Leonetti MD, Marson A. PMID: 29995861; PMCID: PMC6239417.
      View in: PubMed   Mentions: 269     Fields:    Translation:HumansAnimalsCells
    19. Referral patterns and attrition rate for germline testing in pancreatic cancer (PC) patients. Journal of Clinical Oncology. 2018 May 20; 36(15_suppl):1591-1591. Walker WE, Carnevale CJ, Pedley PC, Blanco BA, Chan CS, Collisson CE, Ko KA. .
      View in: Publisher Site   Mentions:
    20. Current and Emerging Therapies in Pancreatic Cancer. Editors: Tanios Bekaii-Saab and Bassel Le-Rayes. Targeting the Tumor Microenvironment. 2018; 235-256. Carnevale J, Ko A.
    21. Targeting the Tumor Microenvironment. Current and Emerging Therapies in Pancreatic Cancer. 2018 Jan 1; 235-256. Carnevale CJ, Ko KA. .
      View in: Publisher Site   Mentions:
    22. The Challenge of Primary Central Nervous System Lymphoma. Hematol Oncol Clin North Am. 2016 Dec; 30(6):1293-1316. Carnevale J, Rubenstein JL. PMID: 27888882; PMCID: PMC5127405.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    23. MM-398 (nanoliposomal irinotecan): emergence of a novel therapy for the treatment of advanced pancreatic cancer. Future Oncol. 2016 Feb; 12(4):453-64. Carnevale J, Ko AH. PMID: 26685802.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    24. Assessing the Significance of BRCA1 and BRCA2 Mutations in Pancreatic Cancer. J Clin Oncol. 2015 Oct 01; 33(28):3080-1. Carnevale J, Ashworth A. PMID: 25987697.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    25. Exploring the association of succinate dehydrogenase complex mutations with lymphoid malignancies. Fam Cancer. 2014 Sep; 13(3):507-11. Renella R, Carnevale J, Schneider KA, Hornick JL, Rana HQ, Janeway KA. PMID: 24781345.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    26. Progress in central nervous system lymphomas. Br J Haematol. 2014 Aug; 166(3):311-25. Wang CC, Carnevale J, Rubenstein JL. PMID: 24837460; PMCID: PMC4107064.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    27. SYK regulates mTOR signaling in AML. Leukemia. 2013 Nov; 27(11):2118-28. Carnevale J, Ross L, Puissant A, Banerji V, Stone RM, DeAngelo DJ, Ross KN, Stegmaier K. PMID: 23535559; PMCID: PMC4028963.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    28. The crimson care collaborative: a student-faculty initiative to increase medical students' early exposure to primary care. Acad Med. 2012 May; 87(5):651-5. Berman R, Powe C, Carnevale J, Chao A, Knudsen J, Nguyen A, Edgman-Levitan S. PMID: 22450186.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    29. Knowledge base and caretaker-child communication about HIV in peri-urban schoolchildren of Lusaka, Zambia. AIDS Care. 2011 May; 23(5):646-53. Carnevale J, Gropper AB, Agnew-Blais J, Mimiaga MJ, Mhango A, Bail R, Ngoma M. PMID: 21293994.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    30. Schistosomiasis haematobium prevalence and risk factors in a school-age population of peri-urban Lusaka, Zambia. J Trop Pediatr. 2010 Aug; 56(4):247-53. Agnew-Blais J, Carnevale J, Gropper A, Shilika E, Bail R, Ngoma M. PMID: 19892835.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    31. The development of sentence interpretation: effects of perceptual, attentional and semantic interference. Dev Sci. 2007 Nov; 10(6):794-813. Leech R, Aydelott J, Symons G, Carnevale J, Dick F. PMID: 17973797.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    Julia's Networks
    Concepts (138)
    Derived automatically from this person's publications.
    Co-Authors (22)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department